Ephrin A1 抗体 (AA 18-182) (FITC)
Quick Overview for Ephrin A1 抗体 (AA 18-182) (FITC) (ABIN7178843)
抗原
See all Ephrin A1 (EFNA1) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 18-182
-
交叉反应
- 大鼠
-
纯化方法
- >95%, Protein G purified
-
免疫原
- Recombinant Rat Ephrin-A1 protein (18-182AA)
-
亚型
- IgG
-
-
-
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Ephrin A1 (EFNA1)
-
别名
- Efna1
-
背景
-
Background: Cell surface GPI-bound ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. Plays an important role in angiogenesis and tumor neovascularization. The recruitment of VAV2, VAV3 and PI3-kinase p85 subunit by phosphorylated EPHA2 is critical for EFNA1-induced RAC1 GTPase activation and vascular endothelial cell migration and assembly. Exerts anti-oncogenic effects in tumor cells through activation and down-regulation of EPHA2. Activates EPHA2 by inducing tyrosine phosphorylation which leads to its internalization and degradation. Acts as a negative regulator in the tumorigenesis of gliomas by down-regulating EPHA2 and FAK. Can evoke collapse of embryonic neuronal growth cone and regulates dendritic spine morphogenesis By similarity.
Aliases: Efna1 antibody, Epgl1 antibody, Lerk1 antibody, Ephrin-A1 antibody, EPH-related receptor tyrosine kinase ligand 1 antibody, LERK-1 antibody, Immediate early response protein B61) [Cleaved into: Ephrin-A1 antibody, secreted form] antibody
-
UniProt
- P97553
-
途径
- RTK signaling
抗原
-